BioCentury
ARTICLE | Company News

Uluru, Melmed Holdings AG sales and marketing update

October 24, 2011 7:00 AM UTC

Uluru signed a letter of intent to grant a Melmed subsidiary exclusive rights to commercialize Altrazeal in the EU. Uluru markets the antimicrobial dressing incorporating the company's Nanoflex nanop...